BEAM vs CE · rev $63.5M vs rev $10.28B
Beam Therapeutics Inc (BEAM) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BEAM currently screens at market cap $2.01B. CE currently screens at market cap $5.92B.
Not investment advice. Open the BEAM and CE stock pages for the full models.
Not investment advice.